Signify Premium Insight: Vendor Financials Roundup – The Health of the Sector Q1 2021

While the coronavirus pandemic was still the most significant factor affecting healthcare vendors in the latest quarter, recently reported financials pointed to a market in tentative recovery. The effects of COVID-19 continued to linger, with substantial variance in performance between different product segments and geographic regions. This is unsurprising given that case numbers and fatalities plummeted, vaccination programmes started to have a measurable effect and restrictions were subsequently eased in some areas, while elsewhere, cases, deaths and disruption skyrocketed. As such, while some vendors were able to start making headway out of the difficulties of the pandemic, for others, the reality is just starting to bite.